2025年3月18日周二，Schrodinger Inc（NASDAQ: SDGR）在2025年KeyBanc年度医疗保健论坛上进行了演讲。在首席执行官Rami Fareed的带领下，讨论重点围绕公司创新的计算机辅助药物研发平台，强调了其进展和挑战。尽管公司去年的财务表现超出预期，但在平衡内部和合作项目方面仍面临持续性任务。

Audiences can expect a “total theatre” experience of dance, musicianship and remarkable puppetry when the latest adaptation of the CS Lewis classic visits Woking ...

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company’s common stock to one newly hired ...

Adding metformin to letrozole and abemaciclib (Verzenio) was tied to deep responses and prolonged progression-free survival ...

Emma’s gone”, I texted one of my closest friends. To the shops? To another country? To another man? I clarified after he ...

Counter-Strike 2's skin market hits $4.27B while Ubisoft's NFT experiment crashed and burned. What made one succeed where the ...

Slit, Which-Path Information, Quantum Superposition Nash, L. (2025) Quantum Entanglement and Young’s Experiment. Journal of ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

The new advancement in quantum error correction involves “squeezing” cat qubits, compressing their quantum state in a way ...

制药技术公司Schrodinger, Inc. (NASDAQ: SDGR )周一宣布任命Bridget van Kralingen加入董事会，即刻生效。该公司市值为15.4亿美元。根据 InvestingPro 数据显示，公司保持强劲的流动性，流动比率为3.31，资产负债表上现金多于债务，但在过去十二个月面临盈利能力挑战，EBITDA为负2.03亿美元。Van ...

Schrödinger, Inc. today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025 ...

Robert Joseph Warrens, an artist celebrated for his provocative, humorous and whimsical storytelling, will exhibit some of ...